Couple thoughts on this:
- Note the off-take is for active anode material, which is why Syrah doesn't need to be qualified first. This product will sell at lower margins than a final anode product (like TLG or NMG) but should still be very profitable.
- If Tesla is signing off take for concentrate, it means they're getting into the anode refinement business (spheriodization and coating). This isn't all that surprising given they're also getting into the lithium refining space.
- The fact that Tesla is getting into refining is not a threat to Talga. First, Tesla currently produces their own cells and purchases cells from other companies (e.g. CATL), so there's no reason to believe they won't do the same with lithium/graphite. Second, the pending graphite shortage likely means Tesla won't be able to make enough anode even if they wanted to. Third, all of the other battery manufacturers (which is the majority of the market) will still be 100% reliant on end anode producers. Fourth, Vittangi provides a superior base material - meaning even Tesla will not be able to beat Talga on quality or cost.
- Forums
- ASX - By Stock
- TLG
- TLG - Media
TLG - Media, page-8510
-
- There are more pages in this discussion • 8,160 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TLG (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.020(5.56%) |
Mkt cap ! $162.9M |
Open | High | Low | Value | Volume |
37.5¢ | 38.5¢ | 37.0¢ | $319.9K | 848.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 80096 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 79880 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 78096 | 0.370 |
3 | 72052 | 0.365 |
27 | 330591 | 0.360 |
4 | 30860 | 0.355 |
13 | 138482 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 79880 | 1 |
0.385 | 38165 | 3 |
0.390 | 3700 | 1 |
0.395 | 70975 | 2 |
0.400 | 9536 | 3 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
TLG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online